SU1131469A3 - Способ получени 4-замещенных производных амино-3-карбэтокси-или 3-циано-1,2-дигидро-2-оксо-1,8-нафтиридина или их солей - Google Patents

Способ получени 4-замещенных производных амино-3-карбэтокси-или 3-циано-1,2-дигидро-2-оксо-1,8-нафтиридина или их солей Download PDF

Info

Publication number
SU1131469A3
SU1131469A3 SU803220198A SU3220198A SU1131469A3 SU 1131469 A3 SU1131469 A3 SU 1131469A3 SU 803220198 A SU803220198 A SU 803220198A SU 3220198 A SU3220198 A SU 3220198A SU 1131469 A3 SU1131469 A3 SU 1131469A3
Authority
SU
USSR - Soviet Union
Prior art keywords
methyl
oxo
dihydro
piperazinyl
naphthyridine
Prior art date
Application number
SU803220198A
Other languages
English (en)
Russian (ru)
Inventor
К.Скотес Энтони
А.Сантилли Артур
Original Assignee
Американ Хоум Продактс Корпорейшн (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Американ Хоум Продактс Корпорейшн (Фирма) filed Critical Американ Хоум Продактс Корпорейшн (Фирма)
Application granted granted Critical
Publication of SU1131469A3 publication Critical patent/SU1131469A3/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SU803220198A 1979-04-18 1980-12-17 Способ получени 4-замещенных производных амино-3-карбэтокси-или 3-циано-1,2-дигидро-2-оксо-1,8-нафтиридина или их солей SU1131469A3 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3125579A 1979-04-18 1979-04-18
US06/125,600 US4324893A (en) 1979-04-18 1980-02-28 4-Amino-3-carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphthyridine derivatives

Publications (1)

Publication Number Publication Date
SU1131469A3 true SU1131469A3 (ru) 1984-12-23

Family

ID=26707004

Family Applications (1)

Application Number Title Priority Date Filing Date
SU803220198A SU1131469A3 (ru) 1979-04-18 1980-12-17 Способ получени 4-замещенных производных амино-3-карбэтокси-или 3-циано-1,2-дигидро-2-оксо-1,8-нафтиридина или их солей

Country Status (22)

Country Link
US (1) US4324893A (cg-RX-API-DMAC7.html)
EP (2) EP0018735B1 (cg-RX-API-DMAC7.html)
JP (1) JPS56500373A (cg-RX-API-DMAC7.html)
KR (1) KR840000076B1 (cg-RX-API-DMAC7.html)
AR (2) AR225437A1 (cg-RX-API-DMAC7.html)
AU (1) AU531348B2 (cg-RX-API-DMAC7.html)
CA (1) CA1115272A (cg-RX-API-DMAC7.html)
DK (1) DK537780A (cg-RX-API-DMAC7.html)
ES (1) ES490645A0 (cg-RX-API-DMAC7.html)
FI (1) FI801229A7 (cg-RX-API-DMAC7.html)
GB (1) GB2053198B (cg-RX-API-DMAC7.html)
GR (1) GR67253B (cg-RX-API-DMAC7.html)
HU (1) HU183125B (cg-RX-API-DMAC7.html)
IE (1) IE49696B1 (cg-RX-API-DMAC7.html)
IL (1) IL59667A (cg-RX-API-DMAC7.html)
IN (1) IN150969B (cg-RX-API-DMAC7.html)
NZ (1) NZ193445A (cg-RX-API-DMAC7.html)
PH (1) PH16524A (cg-RX-API-DMAC7.html)
PT (1) PT71081A (cg-RX-API-DMAC7.html)
SU (1) SU1131469A3 (cg-RX-API-DMAC7.html)
WO (1) WO1980002287A1 (cg-RX-API-DMAC7.html)
YU (1) YU105680A (cg-RX-API-DMAC7.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11434248B2 (en) 2017-09-28 2022-09-06 Nanjing Transthera Biosciences Co. Ltd. PDE9 inhibitor and use thereof
RU2793732C2 (ru) * 2017-09-28 2023-04-05 Транстера Сайенсиз (Наньцзин), Инк. Ингибитор pde9 и его применение

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4420615A (en) * 1981-08-24 1983-12-13 Merck & Co., Inc. Substituted pyridopyrimidines as gastric secretion inhibitors
FR2567520B1 (fr) * 1984-07-11 1987-01-02 Carpibem Nouvelles phenyl-naphthyridines, leur procede de preparation, medicaments les contenant, notamment anti-ulceres
NZ218773A (en) * 1986-01-06 1990-05-28 Carpibem 3-methyl-2-oxo-1-(substituted phenyl)-naphthyridines and pharmaceutical compositions
FR2592650B1 (fr) * 1986-01-06 1988-04-29 Carpibem Nouvelles phenyl-naphtyridines fonctionnalisees en position-3, leur procede de preparation, medicaments les contenant, notamment anti-ulceres.
FR2592651B1 (fr) * 1986-01-06 1988-05-13 Carpibem Nouvelles phenyl naphtyridines comportant un substituant methyle en position 3, et les medicaments qui en contiennent.
FR2592652B1 (fr) * 1986-01-06 1988-04-29 Carpibem Nouvelles phenyl-naphtyridines, leur procede de preparation et les medicaments en contenant.
FR2592649B1 (fr) * 1986-01-06 1988-04-29 Carpibem Cyano et amido phenyl-naphtyridines, leur procede de preparation, medicaments les contenant, notamment anti-ulceres.
NZ218774A (en) * 1986-01-06 1990-06-26 Carpibem 3-substituted phenylnaphthyridines and pharmaceutical compositions
US4916131A (en) * 1986-10-15 1990-04-10 Schering Corporation Naphthyridine derivatives and method for treating allergic reactions
EP0267691A3 (en) * 1986-10-15 1989-08-23 Schering Corporation Use of 1-substituted naphthyridine and pyridopyrazine derivatives for the preparation of medicaments with immunosuppressor activity.
US5037826A (en) * 1986-10-15 1991-08-06 Schering Corporation 1-substituted naphthyridine and pyridopyrazine derivatives
DK273689A (da) * 1988-06-06 1989-12-07 Sanofi Sa 4-amino-3-carboxyquinoliner og -naphthyridiner, fremgangsmaade til deres fremstilling og anvendelse deraf i laegemidler
FR2632861B1 (fr) * 1988-06-15 1990-11-09 Sanofi Sa Derives d'amino-4 carboxy-3 quinoleines et naphtyridines, leur procede de preparation et leur application comme medicaments
FR2632639B1 (fr) * 1988-06-09 1990-10-05 Sanofi Sa Derives d'amino-4 carboxy-3 naphtyridines, leur preparation et compositions pharmaceutiques qui les contiennent
FR2637890B1 (fr) * 1988-09-14 1991-02-01 Europ Propulsion Materiau composite a matrice zircone
GB9318931D0 (en) * 1993-09-14 1993-10-27 Boots Co Plc Therapeutic agents
GB9420168D0 (en) * 1994-10-06 1994-11-23 Boots Co Plc Therapeutic agents
AR029185A1 (es) 1999-10-25 2003-06-18 Yamanouchi Pharma Co Ltd Derivado de naftiridina
MY140679A (en) 2001-05-24 2010-01-15 Avanir Pharmaceuticals Inhibitors of macrohage migration inhibitory factor and methods for identifying the same
KR20020092756A (ko) * 2001-06-05 2002-12-12 이종완 젓갈과 그 제조 방법
TW200418829A (en) 2003-02-14 2004-10-01 Avanir Pharmaceutics Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
WO2004091627A2 (en) * 2003-04-07 2004-10-28 Cylene Pharmaceuticals, Inc. Heterocyclic substituted 1,4-dihydro-4-oxo-1,8-naphthpyridine analogs
MXJL06000006A (es) * 2003-08-22 2006-05-04 Avanir Pharmaceuticals Derivados de naftiridina sustituidos como inhibidores del factor inhibidor de la migracion de macrofagos y su uso en el tratamiento de enfermedades en el hombre.
JP2008534502A (ja) 2005-03-24 2008-08-28 アバニール・ファーマシューティカルズ マクロファージ遊走阻止因子の阻害剤としてのチエノピリジノン誘導体
GB0605689D0 (en) * 2006-03-21 2006-05-03 Novartis Ag Organic compounds
EA202190137A1 (ru) 2018-06-27 2021-05-17 Бристол-Маерс Сквибб Компани Нафтиридиноновые соединения для применения в качестве активаторов t-клеток
CN112654621B (zh) 2018-06-27 2024-05-14 百时美施贵宝公司 可作为t细胞活化剂的经取代萘啶酮化合物
AR119821A1 (es) 2019-08-28 2022-01-12 Bristol Myers Squibb Co Compuestos de piridopirimidinonilo sustituidos útiles como activadores de células t
AR120823A1 (es) 2019-12-23 2022-03-23 Bristol Myers Squibb Co Compuestos bicíclicos sustituidos útiles como activadores de células t
KR20220120624A (ko) 2019-12-23 2022-08-30 브리스톨-마이어스 스큅 컴퍼니 T 세포 활성화제로서 유용한 치환된 피페라진 유도체
AU2020415377A1 (en) 2019-12-23 2022-08-18 Bristol-Myers Squibb Company Substituted quinazolinyl compounds useful as T cell activators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA947301A (en) * 1970-01-28 1974-05-14 Sumitomo Chemical Company Process for the preparation of compound having antibacterial action
CA988522A (en) * 1972-05-05 1976-05-04 Haydn W.R. Williams 1,8-naphthyridine compounds
US3993656A (en) * 1974-11-19 1976-11-23 Merck & Co., Inc. 1,8-Naphthyridine compounds
US4103257A (en) * 1976-05-25 1978-07-25 The United States Of America As Represented By The United States Department Of Energy Azaquinolone dye lasers
US4133885A (en) * 1977-07-18 1979-01-09 Merck & Co., Inc. Substituted naphthyridinones

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
1 . Гетероциклические соединени . Под ред. Р. Эльдерфильда. М., Мир, 1965, с. 179. *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11434248B2 (en) 2017-09-28 2022-09-06 Nanjing Transthera Biosciences Co. Ltd. PDE9 inhibitor and use thereof
RU2793732C2 (ru) * 2017-09-28 2023-04-05 Транстера Сайенсиз (Наньцзин), Инк. Ингибитор pde9 и его применение
RU2814498C2 (ru) * 2019-03-15 2024-02-29 Транстера Сайенсиз (Наньцзин), Инк. Кристаллическая форма ингибитора фосфодиэстеразы, способ ее получения и ее применение
RU2852028C2 (ru) * 2019-03-15 2025-12-02 Транстера Сайенсиз (Наньцзин), Инк. Кристаллическая форма ингибитора фосфодиэстеразы, способ ее получения и ее применение

Also Published As

Publication number Publication date
ES8104286A1 (es) 1981-04-16
AR227427A1 (es) 1982-10-29
AU5751980A (en) 1980-10-23
DK537780A (da) 1980-12-17
US4324893A (en) 1982-04-13
EP0018735B1 (en) 1983-07-27
NZ193445A (en) 1982-09-07
KR840000076B1 (ko) 1984-02-08
EP0018735A1 (en) 1980-11-12
IE800761L (en) 1980-10-18
HU183125B (en) 1984-04-28
IL59667A (en) 1983-11-30
EP0060012B1 (en) 1984-08-29
EP0060012A1 (en) 1982-09-15
YU105680A (en) 1983-09-30
AU531348B2 (en) 1983-08-18
JPS56500373A (cg-RX-API-DMAC7.html) 1981-03-26
FI801229A7 (fi) 1981-01-01
CA1115272A (en) 1981-12-29
AR225437A1 (es) 1982-03-31
IE49696B1 (en) 1985-11-27
WO1980002287A1 (en) 1980-10-30
ES490645A0 (es) 1981-04-16
KR830002759A (ko) 1983-05-30
GR67253B (cg-RX-API-DMAC7.html) 1981-06-26
PH16524A (en) 1983-11-10
PT71081A (en) 1980-05-01
GB2053198B (en) 1983-04-07
IN150969B (cg-RX-API-DMAC7.html) 1983-02-05
GB2053198A (en) 1981-02-04

Similar Documents

Publication Publication Date Title
SU1131469A3 (ru) Способ получени 4-замещенных производных амино-3-карбэтокси-или 3-циано-1,2-дигидро-2-оксо-1,8-нафтиридина или их солей
EP0322133B1 (en) Quinazoline derivatives
SU1140687A3 (ru) Способ получени карбостирильных производных или их фармацевтически приемлемых солей с кислотами
DE69130412T2 (de) Pyrazolopyridinverbindung und Verfahren zu ihrer Herstellung
AU630251B2 (en) Dipyridodiazepines
RU2139288C1 (ru) Алкоксиалкилкарбаматы имидазо[1,2-a]пиридинов и лекарственное средство на их основе
IE57874B1 (en) 1h-imidazo(4,5-c)quinolines and 1h-imidazo(4,5-c)quinolin-4-amines
UA43841C2 (uk) Імідазопіридини та фармацевтична композиція на їх основі
CZ99693A3 (en) Amino quinolone derivatives substituted by aryl or aromatic heterocyclic groups
US4559348A (en) 5- And/or 7-substituted pyrazolo-[4,3-b]-pyridines and their use as antiinflammatory agents
EP0018139B1 (en) Pyrido (2,3-d) pyrimidine derivatives, pharmaceutical compositions containing them and processes for preparing the pyrido (2,3-d) pyrimidine derivatives
DE69011645T2 (de) Cycloheptenopyridinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Antiulkusmitteln.
WO2002002568A1 (de) Pyrimidinderivate und ihre verwendung zur prophylaxe and therapie der zerebralen ischämie
EP0206802B1 (en) Substituted quinoline derivatives
EP0101574A1 (de) 2-Substituierte 1-Aminoalkyl-1,2,3,4-tetrahydro-beta-carboline, ihre Herstellung und Verwendung als Arzneimittel
JPH0363276A (ja) 新規な５，１１―ジヒドロ―６Ｈ―ジピリド〔３，２―ｂ：２′，３′―ｅ〕〔１，４〕ジアゼピン―６―オンおよび該化合物を含有するＡＩＤＳの予防および治療用医薬組成物
FI73999C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara piperazinyl-imidazo/4,5-b/- och -/4,5-c/ pyridiner samt mellanprodukt anvaendbar vid det.
EP0138198B1 (en) Isoindole diuretic derivatives
US4816459A (en) Tetrazolyl-substituted pyrido[1,2-a]pyrimidines and use as SRS-A antagonists
SK197A3 (en) Imidazopyridine-azolidinones, preparation method thereof, pharmaceutical composition containing same and their use
DE69213777T2 (de) Pyridobenzodiazepine, Dipyrido-[3,2-b:2',3'-3] [1,4]-diazepine und deren Verwendung in der Vorbeugung und Behandlung von AIDS
DE69003466T2 (de) Substituierte Thienopyrimidin-Derivate, deren Herstellung, pharmazeutische Zusammensetzungen und medizinische Verwendung.
EP0242230B1 (en) Pyrido [1,2-a] pyrimidine derivatives
US4350817A (en) 4-Cl, Br or I-3-Carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphthyridine derivatives
DE2361757A1 (de) Neue imidazo eckige klammer auf 4,5-b eckige klammer zu pyridine